The findings may help put to rest lingering fears that protection against the virus will be short-lived.
For Apoorva Mandavilli's latest contributions to The Japan Times, see below:
New variants and persistent hesitancy about vaccines will keep the goal out of reach. The virus is here to stay, but vaccinating the most vulnerable may be enough to restore normalcy.
New studies show that one shot of a vaccine can greatly amplify antibody levels in those who have recovered from the coronavirus.
As the coronavirus assumes contagious new forms around the world, two drugmakers reported on Monday that their vaccines, while still effective, offer less protection against one variant and began revising plans to turn back an evolving pathogen that has killed more than 2 million ...
Experts said it was possible that people who had survived mild infections with the coronavirus may still be vulnerable to infection with a new variant.
It will be very hard for the coronavirus to escape the body’s defenses, despite the many variations it may adopt.
People with COVID-19 are most infectious about two days before symptoms begin and for five days afterward, according to a new analysis of previous research.
Scientists who initially warned about contaminated surfaces now say here is little to no evidence that deep cleaning mitigates the threat indoors.
Some survivors of COVID-19 carry worrying signs that their immune system has turned on the body, reminiscent of potentially debilitating diseases like lupus and rheumatoid arthritis, a new study has found. At some point, the body’s defense system in these patients shifted into attacking itself, ...
Experts discuss what is known about reinfections with the coronavirus, and what the phenomenon means for vaccinations and the course of the pandemic.